‹ All Posts
Ketan Mittal (SEBI RA)

29th Oct · SEBI-Registered Analyst

DABUR

Dabur is seeing gradual recovery in volumes as rural demand picks up. Its healthcare and personal care segments are showing steady growth, supported by new product launches. International markets continue to perform well, especially in the Middle East and Africa. The company’s strong distribution reach and Ayurvedic positioning provide competitive advantage. With improving margins and diversification, Dabur remains a quality FMCG compounder.

#PersonalFinance#MacroViews#EquityResearch#PsychologyofMoney#Miscellaneous
811 likes·65 comments